Previous studies have demonstrated that both PRMT5 and MSI2 maintain c-MYC expression in cancer cells through independent mechanisms, but we found MSI2 and PRMT5 cooperate by retaining c-MYC translation. This evidence concerns the gene MSI2 and cancer.